000250.KQ
Sam Chun Dang Pharm. Co., Ltd
KOSDAQKRWEQUITY
DELAYED
Last price
170,100.00
▲ 1,400.00 (0.83%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
168,000.00
Prev close
168,700.00
Day high
173,000.00
Day low
166,500.00
Volume
102.08K
Market cap
$3.98T
P/E (TTM)
—
52W range
120,000.00 – 1,233,000.00
Day trading desk
Gap from prior close
-0.41%
Prior close 168,700.00
VWAP
169,190.98
+0.54% from price
Relative volume
0.46×
Quiet session
Session range
3.90%
166,500.00 – 173,000.00
Position in range
55%
Mid range
ATR (14D)
13,821.43
8.13% of price
Prior day high
177,500.00
PDH
Prior day low
166,000.00
PDL
Bid / ask spread
—
Quote not published
Session volume
99.78K
Avg 215.50K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-10.00%
-8.8%
1M
+2.41%
-0.9%
3M
-52.08%
-54.5%
6M
-68.21%
-80.1%
YTD
-26.84%
-38.8%
1Y
-7.10%
-27.3%
3Y
+220.34%
+145.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on 000250.KQ open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Fundamentals
Market cap$3.98T
Enterprise value—
Revenue (TTM)—
Gross profit—
EBITDA—
Net income—
EPS (TTM)—
Free cash flow—
Total cash—
Total debt—
Book value / share—
Shares outstanding—
Float—
Short % of float—
Dividend yield—
Beta (5Y)—
Valuation & profitability ratios
Trailing P/E—
Forward P/E—
PEG ratio—
Price / sales—
Price / book—
EV / revenue—
EV / EBITDA—
Gross margin—
Operating margin—
Profit margin—
Return on equity—
Return on assets—
Debt / equity—
Current ratio—
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $231.81B | $210.92B | $192.67B | $177.34B | — | +9.9% |
| Operating revenue | $231.81B | $210.92B | $192.67B | $177.34B | — | +9.9% |
| Cost of revenue | $122.43B | $111.26B | $95.70B | $87.34B | — | +10.0% |
| Gross profit | $109.38B | $99.66B | $96.97B | $89.99B | — | +9.7% |
| Research & development | $8.53B | $7.84B | $5.04B | $5.47B | — | +8.8% |
| Selling, general & admin | $58.31B | $56.80B | $51.99B | $45.11B | — | +2.7% |
| Total operating expense | $100.91B | $97.02B | $87.41B | $77.77B | — | +4.0% |
| Operating income | $8.47B | $2.64B | $9.56B | $12.22B | — | +220.5% |
| Net interest income | $2.53B | $4.22B | $210.99M | -$672.68M | — | -40.1% |
| Pre-tax income | $12.52B | $11.04B | -$4.55B | $8.92B | — | +13.4% |
| Tax provision | $487.74M | $16.12B | -$360.77M | $87.70M | — | -97.0% |
| Net income | $5.26B | -$10.92B | -$10.38B | $5.84B | — | +148.2% |
| Net income to common | $5.26B | -$10.92B | -$10.38B | $5.84B | — | +148.2% |
| Basic EPS | 226.00 | -474.00 | -463.00 | 265.00 | — | +147.7% |
| Diluted EPS | 226.00 | -474.00 | -463.00 | 265.00 | — | +147.7% |
| EBIT | $13.50B | $11.42B | -$1.97B | $11.71B | — | +18.2% |
| EBITDA | $24.49B | $20.45B | $6.46B | $19.36B | — | +19.8% |
| Basic shares | 23.28M | 23.03M | 22.42M | 22.03M | — | +1.1% |
| Diluted shares | 23.28M | 23.03M | 22.76M | — | 22.07M | +1.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $95.94B | $105.58B | $40.43B | $22.10B | -9.1% |
| Cash & short-term investments | $129.06B | $141.92B | $92.74B | $86.25B | -9.1% |
| Accounts receivable | $45.58B | $35.54B | $30.43B | $34.95B | +28.3% |
| Inventory | $52.61B | $38.19B | $35.26B | $31.91B | +37.8% |
| Total current assets | $241.76B | $242.53B | $163.91B | $157.75B | -0.3% |
| Property, plant & equipment | $143.09B | $103.60B | $90.01B | $87.21B | +38.1% |
| Goodwill & intangibles | $129.76B | $122.19B | $96.30B | $80.84B | +6.2% |
| Total assets | $561.23B | $519.77B | $408.02B | $372.79B | +8.0% |
| Total current liabilities | $106.57B | $93.42B | $57.96B | $38.16B | +14.1% |
| Current debt | $44.78B | $28.29B | $32.23B | $2.76B | +58.3% |
| Long-term debt | $21.03B | $17.00B | $16.00B | $67.82B | +23.7% |
| Total debt | $69.83B | $49.94B | $53.62B | $76.59B | +39.8% |
| Total liabilities | $197.64B | $170.37B | $109.56B | $127.15B | +16.0% |
| Retained earnings | $95.97B | $95.45B | $106.02B | $112.08B | +0.5% |
| Shareholder equity | $276.02B | $266.11B | $220.50B | $173.74B | +3.7% |
| Working capital | $135.19B | $149.11B | $105.95B | $119.59B | -9.3% |
| Net tangible assets | $146.26B | $143.92B | $124.20B | $92.90B | +1.6% |
| Shares issued | 23.41M | 23.46M | 23.46M | 22.77M | -0.2% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | $12.03B | -$5.08B | -$4.19B | $8.83B | +336.9% |
| Depreciation & amortisation | $10.99B | $9.03B | $8.43B | $7.65B | +21.8% |
| Stock-based compensation | -$503.28M | $519.16M | $81.41M | — | -196.9% |
| Change in working capital | $1.96B | $1.30B | $726.09M | -$10.42B | +50.9% |
| Operating cash flow | $9.79B | $21.77B | $23.43B | $13.28B | -55.0% |
| Capital expenditure | -$59.59B | -$41.30B | -$21.97B | -$46.55B | -44.3% |
| Investing cash flow | -$42.36B | -$23.16B | -$8.42B | -$53.94B | -82.9% |
| Share buybacks | — | — | — | -$5.96B | — |
| Dividends paid | -$4.65B | -$890.15M | -$880.82M | -$968.35M | -422.6% |
| Financing cash flow | $22.78B | $65.76B | $3.39B | $13.33B | -65.4% |
| Free cash flow | -$49.79B | -$19.53B | $1.45B | -$33.27B | -155.0% |
| End cash position | $95.94B | $105.58B | $40.43B | $22.10B | -9.1% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $64.87B | $66.26B | $58.02B | $56.90B | $50.62B | -2.1% |
| Operating revenue | $64.87B | $66.26B | $58.02B | $56.90B | $50.62B | -2.1% |
| Cost of revenue | $32.99B | $34.70B | $30.91B | $31.00B | $25.81B | -4.9% |
| Gross profit | $31.88B | $31.56B | $27.11B | $25.90B | $24.81B | +1.0% |
| Research & development | $1.64B | $1.73B | $1.01B | $4.57B | $1.22B | -4.8% |
| Selling, general & admin | $15.84B | $15.14B | $14.66B | $14.24B | $14.27B | +4.6% |
| Total operating expense | $26.43B | $26.14B | $23.68B | $26.98B | $24.12B | +1.1% |
| Operating income | $5.45B | $5.42B | $3.43B | -$1.08B | $687.68M | +0.4% |
| Net interest income | $120.30M | $700.05M | $132.89M | $624.51M | $612.87M | -82.8% |
| Pre-tax income | $8.43B | $7.43B | $5.25B | -$1.72B | $1.55B | +13.5% |
| Tax provision | $1.53B | -$474.71M | $789.23M | -$105.64M | $278.86M | +421.9% |
| Net income | $5.45B | $5.55B | $2.57B | -$3.34B | $478.23M | -1.8% |
| Net income to common | $5.45B | $5.55B | $2.57B | -$3.34B | $478.23M | -1.8% |
| Basic EPS | 233.00 | — | 111.00 | -143.00 | 21.00 | — |
| Diluted EPS | 233.00 | — | 111.00 | -143.00 | 21.00 | — |
| EBIT | $8.93B | $7.50B | $5.84B | -$1.94B | $2.11B | +19.1% |
| EBITDA | $12.12B | $10.69B | $8.08B | $1.13B | $4.58B | +13.3% |
| Basic shares | 23.37M | — | 23.26M | 23.26M | 22.77M | — |
| Diluted shares | 23.37M | — | 23.26M | 23.26M | 22.77M | — |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Cash & equivalents | $84.21B | $95.94B | $103.14B | $81.47B | $82.83B | — | -12.2% |
| Cash & short-term investments | $110.37B | $129.06B | $117.10B | $104.90B | $127.64B | — | -14.5% |
| Accounts receivable | $54.31B | $45.58B | $38.55B | $36.96B | $36.85B | — | +19.2% |
| Inventory | $48.71B | $52.61B | $47.75B | $46.81B | $41.32B | — | -7.4% |
| Total current assets | $240.30B | $241.76B | $221.32B | $201.16B | $212.75B | — | -0.6% |
| Property, plant & equipment | $150.45B | $143.09B | $132.25B | $113.22B | $104.60B | — | +5.1% |
| Goodwill & intangibles | $135.86B | $129.76B | $127.52B | $120.95B | $124.97B | — | +4.7% |
| Total assets | $573.12B | $561.23B | $529.96B | $486.24B | $493.79B | — | +2.1% |
| Total current liabilities | $109.98B | $106.57B | $89.25B | $68.38B | $70.27B | — | +3.2% |
| Current debt | $44.71B | $44.78B | $45.64B | $29.26B | $28.82B | — | -0.2% |
| Long-term debt | — | $21.03B | $21.15B | $17.00B | $17.00B | $17.00B | — |
| Total debt | $48.72B | $69.83B | $71.09B | $50.76B | $50.17B | — | -30.2% |
| Total liabilities | $178.65B | $197.64B | $174.97B | $142.34B | $147.54B | — | -9.6% |
| Retained earnings | $100.22B | $95.97B | $90.34B | $87.87B | $91.25B | — | +4.4% |
| Shareholder equity | $298.21B | $276.02B | $267.53B | $258.32B | $262.05B | — | +8.0% |
| Working capital | $130.31B | $135.19B | $132.07B | $132.79B | $142.48B | — | -3.6% |
| Net tangible assets | $162.35B | $146.26B | $140.01B | $137.37B | $137.08B | — | +11.0% |
| Shares issued | 23.46M | 23.41M | 23.46M | 23.46M | 23.46M | — | +0.2% |
| Line item | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | YoY |
|---|---|---|---|---|---|---|---|
| Net income | $6.91B | $7.91B | $4.46B | -$1.61B | $1.28B | — | -12.7% |
| Depreciation & amortisation | $3.19B | $3.20B | $2.24B | $3.08B | $2.47B | — | -0.3% |
| Stock-based compensation | — | -$4.62M | $0 | -$629.63M | $130.97M | $141.81M | — |
| Change in working capital | -$18.60B | -$3.12B | $7.47B | -$14.07B | $11.68B | — | -496.5% |
| Operating cash flow | -$9.70B | $9.63B | $14.12B | -$15.17B | $1.23B | — | -200.8% |
| Capital expenditure | -$20.49B | -$9.76B | -$33.12B | -$6.73B | -$9.97B | — | -109.9% |
| Investing cash flow | -$12.54B | -$16.01B | -$21.93B | $15.48B | -$19.91B | — | +21.6% |
| Dividends paid | — | $0 | $0 | $0 | -$4.65B | $0 | — |
| Financing cash flow | $9.39B | -$1.27B | $28.47B | $149.65M | -$4.56B | — | +836.3% |
| Free cash flow | -$30.19B | -$139.09M | -$19.00B | -$21.90B | -$8.75B | — | -21,606.0% |
| End cash position | $84.21B | $95.94B | $103.14B | $81.47B | $82.83B | — | -12.2% |
Options analytics
Put / call volume
—
—
Put / call open interest
—
Positioning, not flow
Max pain
—
—
ATM implied vol
—
Nearest strike to spot
Skew (10% OTM)
—
—
Call volume
0
Contracts, this expiry
Put volume
0
Contracts, this expiry
Heaviest call OI
—
—
Heaviest put OI
—
—
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Mar 2024 | — | 50.00 | — |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | — | — | $0 | — |
| Next quarter | — | — | $0 | — |
| Current year | — | — | $0 | — |
| Next year | — | — | $0 | — |
Analyst targets & ownership
Mean target—
High target—
Low target—
Implied upside—
Analyst count—
ConsensusNONE
Strong buy / Buy— / —
Hold—
Sell / Strong sell— / —
Held by insiders—
Held by institutions—
Institutions holding—
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
183,140.00
-7.12% from price
SMA 20
167,415.00
+1.60% from price
SMA 50
195,678.00
-13.07% from price
SMA 100
319,689.00
-46.79% from price
SMA 200
370,182.00
-54.05% from price
EMA 12
176,417.01
-3.58% from price
EMA 26
181,059.58
-6.05% from price
EMA 50
214,540.49
-20.71% from price
RSI (14)
44.8
Neutral
MACD (12,26,9)
-4,642.57
Hist 3,009.88
ATR (14)
13,821.43
8.13% of price
Realised vol 30D
159.6%
Annualised
Bollinger upper
206,552.77
20, 2σ
Bollinger lower
128,277.23
20, 2σ
50 / 200 cross
Death
195,678.00 vs 370,182.00
Trend bias
Below 200
-54.05%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.02
Less volatile than market
Correlation to SPY
0.00
Largely independent
Realised vol 30D
159.6%
Annualised
Market vol 1Y
12.8%
SPY, annualised
Max drawdown 1Y
-89.3%
Peak to trough
Max drawdown 5Y
-89.3%
Peak to trough
ATR 14
13,821.43
8.13% of price
Beta (reported)
—
5Y monthly, from filing
Headlines
Canada Commodities: Oil Prices Fall as US Weighs Tougher Sanctions Against Iran
MT Newswires · 3m ago
Capricor Therapeutics Says FDA Target Action Date for Deramiocel Extended by Three Months
MT Newswires · 4m ago
Qiagen Names Jonathan Pratt as Chief Executive
MT Newswires · 4m ago
Startup World Cup Returns to San Francisco for 2026 Grand Finale
Business Wire · 4m ago
A First for COR Auditing: AuditSoft Launches AI Assistant
Business Wire · 4m ago
Here’s How Denim Makers Can Offer Stretch & Go Plastic-Free
Sourcing Journal · 4m ago
Ryan Named to The Atlanta Journal-Constitution’s 2026 Top Workplaces List
Business Wire · 4m ago
Trellix Expands Leadership Team to Accelerate Growth and Cyber Resilience
Business Wire · 4m ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.